Comparative efficacy and tolerability of beclomethasone/formoterol and fluticasone/salmeterol fixed combination in Taiwanese asthmatic patients

Journal of the Formosan Medical Association

Volumn 117, Issue 12, 2018, Pages 1078-1085

  Hsieh, Meng Jer ^a,b   Lin, Yu Ching ^a   Lai, Ruay Sheng ^c   Wu, Chien Liang ^d   Lai, Chun Liang ^e,i   Wang, Chin Chou ^a   Perng, Diahn Warng ^f   Kao, Shang Jyh ^g   Chang, En Ting ^h,i   Wang, Hao Chien ^j   Perng, Wann Cherng ^k   Hsu, Jeng Yuan ^l   Lin, Ching Hsiung ^m   Tsai, Ying Huang ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d MACKAY MEMORIAL HOSPITAL   (Taiwan)

^e Dalin Tzu Chi Hospital   (Taiwan)

^f TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^g SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^h BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

ⁱ TZU CHI UNIVERSITY   (Taiwan)

^j NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^k TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^l TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^m CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

more..

Author keywords

Asthma; Combination therapy; Inhaled corticosteroid; Long acting beta2 agonist; Pulmonary hyperinflation

Indexed keywords

BECLOMETASONE; FLUTICASONE; FORMOTEROL; SALMETEROL; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL FUMARATE;

ADULT; AGED; ARTICLE; ASTHMA; ASTHMA CONTROL TEST; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HYPERINFLATION; INTENTION TO TREAT ANALYSIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT SAFETY; PEAK EXPIRATORY FLOW; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; TAIWANESE; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION; CLINICAL TRIAL; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; TAIWAN;

ADMINISTRATION, INHALATION; ADULT; ASTHMA; BECLOMETHASONE; DOUBLE-BLIND METHOD; FEMALE; FLUTICASONE-SALMETEROL DRUG COMBINATION; FORCED EXPIRATORY VOLUME; FORMOTEROL FUMARATE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TAIWAN;

EID: 85039551742     PISSN: 09296646     EISSN: 18760821     Source Type: Journal    
DOI: 10.1016/j.jfma.2017.12.005     Document Type: Article

References (20)

1. Hwang, C.Y., Chen, Y.J., Lin, M.W., Chen, T.J., Chu, S.Y., Chen, C.C., et al. Prevalence of atopic dermatitis, allergic rhinitis and asthma in Taiwan: a national study 2000 to 2007. Acta Derm Venereol 90:6 (2010), 589–594.
2. Lee, Y.L., Hwang, B.F., Lin, Y.C., Guo, Y.L., Taiwan Childhood Allergy Survey G. Time trend of asthma prevalence among school children in Taiwan. [corrected]. Pediatr Allergy Immunol 18:3 (2007), 188–195.
3. Ma, Y.C., Lin, C.C., Yang, S.Y., Chen, H.J., Li, T.C., Lin, J.G., Time trend analysis of the prevalence and incidence of diagnosed asthma and traditional Chinese medicine use among adults in Taiwan from 2000 to 2011: a population-based study. PLoS One, 10(10), 2015, e0140318.
4. Global Initiative for Asthma (GINA), Global strategy for asthma management and prevention (2017 update). 2017.
5. National Asthma Education and Prevention Program (NAEPP), Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary Report 2007. J Allergy Clin Immunol 120:5 Suppl. (2007), S94–S138.
6. Greening, A.P., Ind, P.W., Northfield, M., Shaw, G., Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 344:8917 (1994), 219–224.
7. Lalloo, U.G., Malolepszy, J., Kozma, D., Krofta, K., Ankerst, J., Johansen, B., et al. Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma. Chest 123:5 (2003), 1480–1487.
8. O'Byrne, P.M., Naya, I.P., Kallen, A., Postma, D.S., Barnes, P.J., Increasing doses of inhaled corticosteroids compared to adding long-acting inhaled beta2-agonists in achieving asthma control. Chest 134:6 (2008), 1192–1199.
9. Huchon, G., Magnussen, H., Chuchalin, A., Dymek, L., Gonod, F.B., Bousquet, J., Lung function and asthma control with beclomethasone and formoterol in a single inhaler. Respir Med 103:1 (2009), 41–49.
10. Papi, A., Paggiaro, P., Nicolini, G., Vignola, A.M., Fabbri, L.M., Group ISs. Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma. Allergy 62:10 (2007), 1182–1188.
11. Sturton, G., Persson, C., Barnes, P.J., Small airways: an important but neglected target in the treatment of obstructive airway diseases. Trends Pharmacol Sci 29:7 (2008), 340–345.
12. van den Berge, M., ten Hacken, N.H.T., van der Wiel, E., Postma, D.S., Treatment of the bronchial tree from beginning to end: targeting small airway inflammation in asthma. Allergy 68:1 (2013), 16–26.
13. Calverley, P.M.A., Kuna, P., Monsó E., Costantini, M., Petruzzelli, S., Sergio, F., et al. Beclomethasone/formoterol in the management of COPD: a randomised controlled trial. Respir Med 104:12 (2010), 1858–1868.
14. Fabbri, L.M., Nicolini, G., Olivieri, D., Papi, A., Inhaled beclometasone dipropionate/formoterol extra-fine fixed combination in the treatment of asthma: evidence and future perspectives. Expert Opin Pharmacother 9:3 (2008), 479–490.
15. Leach, C., Targeting inhaled steroids. Int J Clin Pract Suppl 96 (1998), 23–27.
16. De Backer, W., Devolder, A., Poli, G., Acerbi, D., Monno, R., Herpich, C., et al. Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients. J Aerosol Med Pulm Drug Deliv 23:3 (2010), 137–148.
17. Fireman, P., Prenner, B.M., Vincken, W., Demedts, M., Mol, S.J., Cohen, R.M., Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol. Ann Allergy Asthma Immunol 86:5 (2001), 557–565.
18. van Schayck, C.P., Donnell, D., The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (part 2): clinical experience in children. Int J Clin Pract 58:8 (2004), 786–794.
19. Menzies, D., Nair, A., Hopkinson, P., McFarlane, L., Lipworth, B.J., Differential anti-inflammatory effects of large and small particle size inhaled corticosteroids in asthma. Allergy 62:6 (2007), 661–667.
20. Vanden Burgt, J.A., Busse, W.W., Martin, R.J., Szefler, S.J., Donnell, D., Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma. J Allergy Clin Immunol 106:6 (2000), 1209–1226.